Kerry expands plant protein capabilities with Pevesa Biotech buy

Credit: Oksana Shufrych

Kerry has expanded its non-allergenic and organic plant protein capability by acquiring Spanish company Pevesa Biotech.

The deal enhances Kerry’s positioned in the hydrolysed plant protein space for specialised nutrition and expands its capacity to serve the rapidly growing, high-quality, organic plant protein market.

Pevesa Biotech offer a range of high-quality plant proteins, including organic pea and rice protein and protein hydrolysates and is a European leader in non-allergenic plant proteins for infant nutrition.

It has also developed a range of organic and standard biofertilizers for fruit, olive and specialist garden growers, and has had a strong corporate focus for many years on developing sustainable solutions to important nutrition, health, biowaste and agricultural challenges.

“Kerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market,” said John Reilly, VP of Business Development Proteins at Kerry.

“This will be a good fit with Kerry’s growing plant protein product portfolio, and Pevesa’s customers will benefit from the synergy between its market-leading technology and Kerry’s protein processing expertise.”